Literature DB >> 21090962

The brain-gut axis in abdominal pain syndromes.

Emeran A Mayer1, Kirsten Tillisch.   

Abstract

The importance of bidirectional brain-gut interactions in gastrointestinal (GI) illness is increasingly recognized, most prominently in the area of functional GI syndromes such as irritable bowel syndrome (IBS), functional dyspepsia, and functional chest pain. The brain receives a constant stream of interoceptive input from the GI tract, integrates this information with other interoceptive information from the body and with contextual information from the environment, and sends an integrated response back to various target cells within the GI tract. This system is optimized to assure homeostasis of the GI tract during physiological perturbations and to adapt GI function to the overall state of the organism. In health, the great majority of interoceptive information reaching the brain is not consciously perceived but serves primarily as input to autonomic reflex pathways. In patients with functional abdominal pain syndromes, conscious perception of interoceptive information from the GI tract, or recall of interoceptive memories of such input, can occur in the form of constant or recurrent discomfort or pain. This is often associated with alterations in autonomic nervous system output and with emotional changes. A model is proposed that incorporates reported peripheral and central abnormalities in patients with IBS, extrapolates similar alterations in brain-gut interactions to patients with other chronic abdominal pain syndromes, and provides novel treatment targets.

Entities:  

Mesh:

Year:  2011        PMID: 21090962      PMCID: PMC3817711          DOI: 10.1146/annurev-med-012309-103958

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  71 in total

Review 1.  The neurobiology of stress and gastrointestinal disease.

Authors:  E A Mayer
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

Review 2.  Ascending visceral regulation of cortical affective information processing.

Authors:  Gary G Berntson; Martin Sarter; John T Cacioppo
Journal:  Eur J Neurosci       Date:  2003-10       Impact factor: 3.386

Review 3.  Pathogenesis of irritable bowel syndrome: the mast cell connection.

Authors:  Javier Santos; Mar Guilarte; Carmen Alonso; J R Malagelada
Journal:  Scand J Gastroenterol       Date:  2005-02       Impact factor: 2.423

4.  Role for protease activity in visceral pain in irritable bowel syndrome.

Authors:  Nicolas Cenac; Christopher N Andrews; Marinella Holzhausen; Kevin Chapman; Graeme Cottrell; Patricia Andrade-Gordon; Martin Steinhoff; Giovanni Barbara; Paul Beck; Nigel W Bunnett; Keith A Sharkey; Jose Geraldo P Ferraz; Eldon Shaffer; Nathalie Vergnolle
Journal:  J Clin Invest       Date:  2007-02-15       Impact factor: 14.808

5.  Cognitive therapy for irritable bowel syndrome is associated with reduced limbic activity, GI symptoms, and anxiety.

Authors:  Jeffrey M Lackner; Mary Lou Coad; Howard R Mertz; David S Wack; Leonard A Katz; Susan S Krasner; Rebecca Firth; Thomas C Mahl; Alan H Lockwood
Journal:  Behav Res Ther       Date:  2005-07-21

Review 6.  Fibromyalgia: a disorder of the brain?

Authors:  Petra Schweinhardt; Khara M Sauro; M Catherine Bushnell
Journal:  Neuroscientist       Date:  2008-02-12       Impact factor: 7.519

Review 7.  Brain imaging approaches to the study of functional GI disorders: a Rome working team report.

Authors:  E A Mayer; Q Aziz; S Coen; M Kern; J S Labus; R Lane; B Kuo; B Naliboff; I Tracey
Journal:  Neurogastroenterol Motil       Date:  2009-06       Impact factor: 3.598

Review 8.  The role of the mast cell in interstitial cystitis.

Authors:  G R Sant; T C Theoharides
Journal:  Urol Clin North Am       Date:  1994-02       Impact factor: 2.241

Review 9.  Chronic pain and medullary descending facilitation.

Authors:  Frank Porreca; Michael H Ossipov; G F Gebhart
Journal:  Trends Neurosci       Date:  2002-06       Impact factor: 13.837

Review 10.  Critical role of mast cells in inflammatory diseases and the effect of acute stress.

Authors:  Theoharis C Theoharides; David E Cochrane
Journal:  J Neuroimmunol       Date:  2004-01       Impact factor: 3.478

View more
  138 in total

Review 1.  Interoceptive dysfunction: toward an integrated framework for understanding somatic and affective disturbance in depression.

Authors:  Christopher Harshaw
Journal:  Psychol Bull       Date:  2014-11-03       Impact factor: 17.737

2.  Genome-wide DNA methylation profiling of peripheral blood mononuclear cells in irritable bowel syndrome.

Authors:  S Mahurkar; C Polytarchou; D Iliopoulos; C Pothoulakis; E A Mayer; L Chang
Journal:  Neurogastroenterol Motil       Date:  2015-12-16       Impact factor: 3.598

Review 3.  Gut feelings: the emerging biology of gut-brain communication.

Authors:  Emeran A Mayer
Journal:  Nat Rev Neurosci       Date:  2011-07-13       Impact factor: 34.870

Review 4.  Approach to a Child with Functional Abdominal Pain.

Authors:  Manu R Sood; Sravan Reddy Matta
Journal:  Indian J Pediatr       Date:  2016-04-22       Impact factor: 1.967

Review 5.  Crosstalk at the mucosal border: importance of the gut microenvironment in IBS.

Authors:  Lena Öhman; Hans Törnblom; Magnus Simrén
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2014-12-02       Impact factor: 46.802

6.  Eluxadoline: a promising therapy that raises many questions.

Authors:  Brooks D Cash
Journal:  Transl Gastroenterol Hepatol       Date:  2016-09-28

Review 7.  Overlap between functional GI disorders and other functional syndromes: what are the underlying mechanisms?

Authors:  S E Kim; L Chang
Journal:  Neurogastroenterol Motil       Date:  2012-08-02       Impact factor: 3.598

8.  New and Emerging Treatment Options for Irritable Bowel Syndrome.

Authors:  Brian E Lacy; William D Chey; Anthony J Lembo
Journal:  Gastroenterol Hepatol (N Y)       Date:  2015-04

9.  Effect of hypnotherapy and educational intervention on brain response to visceral stimulus in the irritable bowel syndrome.

Authors:  M B O Lowén; E A Mayer; M Sjöberg; K Tillisch; B Naliboff; J Labus; P Lundberg; M Ström; M Engström; S A Walter
Journal:  Aliment Pharmacol Ther       Date:  2013-04-25       Impact factor: 8.171

10.  Type, rather than number, of mental and physical comorbidities increases the severity of symptoms in patients with irritable bowel syndrome.

Authors:  Jeffrey M Lackner; Chang-Xing Ma; Laurie Keefer; Darren M Brenner; Gregory D Gudleski; Nikhil Satchidanand; Rebecca Firth; Michael D Sitrin; Leonard Katz; Susan S Krasner; Sarah K Ballou; Bruce D Naliboff; Emeran A Mayer
Journal:  Clin Gastroenterol Hepatol       Date:  2013-03-21       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.